GRHIX
Price
$19.34
Change
+$0.15 (+0.78%)
Updated
Oct 7 closing price
Net Assets
698.57M
PRNEX
Price
$43.02
Change
-$0.01 (-0.02%)
Updated
Oct 7 closing price
Net Assets
2.48B
Interact to see
Advertisement

GRHIX vs PRNEX

Header iconGRHIX vs PRNEX Comparison
Open Charts GRHIX vs PRNEXBanner chart's image
Goehring & Rozencwajg Resources Instl
Price$19.34
Change+$0.15 (+0.78%)
VolumeN/A
Net Assets698.57M
T. Rowe Price New Era
Price$43.02
Change-$0.01 (-0.02%)
VolumeN/A
Net Assets2.48B
GRHIX vs PRNEX Comparison Chart in %
View a ticker or compare two or three
VS
GRHIX vs. PRNEX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRHIX is a Buy and PRNEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRNEX has more cash in the bank: 2.48B vs. GRHIX (699M). GRHIX pays higher dividends than PRNEX: GRHIX (2.71) vs PRNEX (1.81). GRHIX was incepted earlier than PRNEX: GRHIX (9 years) vs PRNEX (57 years). GRHIX (1.23) is less costly to investors than PRNEX (0.77). PRNEX (24.30) and GRHIX (24.00) have comparable annual turnover. PRNEX has a lower initial minimum investment than GRHIX: PRNEX (2500) vs GRHIX (100000). GRHIX annual gain was more profitable for investors over the last year : 43.42 vs. PRNEX (4.04). GRHIX return over 5 years is better than : 310.95 vs. PRNEX (65.83).
GRHIXPRNEXGRHIX / PRNEX
Total Expense Ratio0.960.77125%
Annual Report Gross Expense Ratio1.230.77160%
Fund Existence9 years57 years-
Gain YTD52.66515.797333%
Front LoadN/AN/A-
Min. Initial Investment10000025004,000%
Min. Initial Investment IRAN/AN/A-
Net Assets699M2.48B28%
Annual Yield % from dividends2.711.81149%
Returns for 1 year43.424.041,074%
Returns for 3 years72.8719.63371%
Returns for 5 years310.9565.83472%
Returns for 10 yearsN/A63.87-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SDMGX22.60N/A
N/A
Sit Developing Markets Growth
SHSSX67.81N/A
N/A
BlackRock Health Sciences Opps Instl
RLCAX9.33N/A
N/A
Columbia Disciplined Value A
QQMNX20.93N/A
N/A
Federated Hermes MDT Market Neutral IS
FCUEX20.59-0.15
-0.72%
NYLI PineStone U.S. Equity Class A